PREGNANCY OUTCOMES AND RISK FACTORS IDENTIFICATION WITH GROUP-B STREPTOCOCCUS INFECTION : A CLINICAL STUDY

Nazma Akter, Xiaohua Luo, Most. Runa Parvin, Ahmed Ferdous

Abstract


Objective: The present study was undertaken to study the prevalence, risk factors and pregnancy outcomes of GBS colonization at their third trimester. Materials & Methods: The present study was a prospective, hospital-based study conducted at the Third Affiliated Hospital of Zhengzhou University of China, between January 2018 to December 2018 and Mother & Child Community Hospital, Bogra, Bangladesh between June 2018 to September 2019. A total of 995 pregnant women from Bangladesh and 1090 pregnant women from China between their 35-37 weeks of gestation were consecutively included in the study. Rectovaginal swab was collected to determine whether they carry GBS or not. Then both groups of pregnant women (pregnant women with and without GBS) were prospectively followed to see the maternal outcomes. Immediately after delivery (within 1 hour), the aural swab from the neonates with GBS positive mothers were collected in delivery or room to see GBS positivity. Results: In the present study 15% of the Bangladeshi pregnant women and 50% of Chinese women had rectovaginal colonization of GBS. In multivariate analysis, GDM, PIH and oligohydramnios emerged as independent predictors of GBS colonization. Although Bangladeshi data demonstrated adverse pregnancy outcomes like PROM and clinical chorioamnionitis in pregnant women with GBS colonization, Chinese data did not prove so. About 16 and 19% of the Neonates with maternal GBS colonization in Bangladeshi and Chinese samples respectively were GBS positive. Conclusion: The study concluded that rectovaginal colonization of GBS during pregnancy is no less and the risk factors for colonization of GBS are GDM, PIH and oligohydramnios. A sizable proportion of neonates (one in six) with maternal GBS positivity may have neonatal GBS positivity.

 


Keywords


Maternal GBS colonization, risk factors, pregnancy outcome, neonatal GBS positivity

Full Text:

PDF

References


Tudela CM, Stewart RD, Roberts SW, Wendel GD, Stafford IA, McIntire DD et al. Intrapartum evidence of early-onset group B streptococcus. Obstet Gynecol. 2012;119(3):626–9.

Nan C, Dangor Z, Cutland CL, Edwards MS, Madhi SA, Cunnington MC. Maternal group B Streptococcus-related stillbirth: a systematic review. BJOG. 2015;122(11):1437–45.

Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999;103(6):e77.

Melin P, Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine. 2013;31(Suppl 4):D31–D42.

Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016–25.

Edmond KM, Kortsalioudaki C, Scott S, Schrag SJ, Zaidi AKM, Cousens S et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet. 2012;379(9815):547–56.

Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT et al. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S160–72.

Schuchat A. Group B streptococcus. Lancet. 1999;353(9146):51–6.

Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep. 1996;45:1–24.

Kwatra G, Cunnington MC, Merrall E, Adrian PV, Ip M, Klugman KP, et al. Prevalence of maternal colonisation with Group B streptococcus: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(9):1076–84.

Clouse K, Shehabi A, Suleimat AM, Faouri S, Khuri-Bulos N, Al-Jammal A et al. High prevalence of Group B Streptococcus colonization among pregnant women in Amman, Jordan. BMC Pregnancy Childbirth. 2019;19:177.

Costa AL, Lamy Filho F, Chein MB, Brito LM, Lamy ZC, Andrade KL. Prevalence of colonization by group B Streptococcus in pregnant women from a public maternity of Northwest region of Brazil. Rev Bras Ginecol Obstet. 2008;30:274–80.

Dechen TC, Sumit K, Pal R. Correlates of Vaginal Colonization with Group B Streptococci among Pregnant Women. J Glob Infect Dis 2010;2(3):236–41.

Kovavisarach E, Ying WS, Kanjanahareutai S. Risk factors related to group B streptococcal colonization in pregnant women in labor. J Med Assoc Thai. 2007;90:1287–92.

Alkenburg-van den Berg AW, Sprij AJ, Oostvogel PM, Mutsaers JA, Renes WB, Rosendaal FR, et al. Prevalence of colonisation with group B Streptococci in pregnant women of a multi-ethnic population in The Netherlands. Eur J Obstet Gynecol Reprod Biol. 2006;124:178–83.

Papapetropoulou M, Kondakis XG. A study of risk factors of vaginal colonization with group B streptococci in pregnancy. Eur J Epidemiol. 1987;3:419–22.

Kim EJ, Oh KY, Kim MY, Seo YS, Shin JH, Song YR et al. Risk Factors for Group B Streptococcus Colonization Among Pregnant Women in Korea. Epidemiol Health. 2011;33:e2011010.

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap L, Wenstrom KD. 22nd edition. New York: McGraw-Hill; 2005. Williams Obstetrics; pp. 1284–99.

Winn HN. Group B streptococcus infection in pregnancy. Clin Perinatol. 2007;34:387–392.

Schuchat A. Group B streptococcal disease in newborns: a global perspective on prevention. Biomed Pharmacother. 1995;49:19–25.

Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P. Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol. 1994;84:816–9.

Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M et al. Sentinel Health Unit Surveillance System Site Coordinators. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. J Infect Dis. 2000;182:168–73.

Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013;31(Suppl 4):D20–D26.

Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J et al. Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(suppl_2):S100–S111.


Refbacks

  • There are currently no refbacks.